Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2
dc.contributor.author | Kole, Kerry L. | en_US |
dc.contributor.author | Gyetko, Margaret R. | en_US |
dc.contributor.author | Simpson, Robert U. | en_US |
dc.contributor.author | Sitrin, Robert G. | en_US |
dc.date.accessioned | 2006-04-10T14:48:23Z | |
dc.date.available | 2006-04-10T14:48:23Z | |
dc.date.issued | 1991-02-15 | en_US |
dc.identifier.citation | Kole, Kerry L., Gyetko, Margaret R., Simpson, Robert U., Sitrin, Robert G. (1991/02/15)."Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2." Biochemical Pharmacology 41(4): 585-591. <http://hdl.handle.net/2027.42/29456> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T4P-4777WWV-1CF/2/ec9c6b70932beec4e644af0c8261c192 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/29456 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1900005&dopt=citation | en_US |
dc.description.abstract | Calcitriol-induced differentiation of U937 mononuclear phagocytes is known to have divergent effects on the synthesis of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-2 (PAI-2). In this study, we sought to determine whether calcitriol affects the expression of these proteins by modulating intermediate signal trasduction involving intracellular calcium and protein kinase C (PKC). U937 cells were stimulated with calcitriol (50 nM) for 6-72 hr, inducing a transient increase in specific binding of [3H]phorbol dibutyrate ([3H]PDBu), seen only after 24 hr. Staurosporine (2 nM), a PKC inhibitor, had no effect on calcitriol-induced secretion of plasminogen activator (PA) activity. However, staurosporine significantly (P < 0.05) inhibited the ability of calcitriol to enhance phorbol myristate acetate (PMA)-induced secretion of PA inhibitor activity, indicating that this priming effect of calcitriol requires expression of PKC. The calcium ionophore A23187 (0.1 [mu]M) induced a modest increase in secreted PA inhibitor activity, in contrast to the secretion of PA activity which is consistently seen in response to calcitriol. Northern blot analysis demonstrated that A23187 induced an increase in PAI-2 mRNA and a marked reduction in uPA mRNA, while calcitriol induced opposite changes in both mRNA species. We conclude that calcitriol modulates uPA and PAI-2 expression by multiple mechanisms that are both PKC dependent and PKC independent. Our studies also demonstrated that increased intracellular calcium alters the synthesis of both uPA and PAI-2 in a manner which favors expression of PA inhibitor activity. | en_US |
dc.format.extent | 775818 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical Center, Ann Arbor Michigan, U.S.A.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Michigan, U.S.A. | en_US |
dc.contributor.affiliationum | Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Michigan, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical Center, Ann Arbor Michigan, U.S.A. | en_US |
dc.contributor.affiliationum | Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Michigan, U.S.A. | en_US |
dc.identifier.pmid | 1900005 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/29456/1/0000538.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0006-2952(91)90631-E | en_US |
dc.identifier.source | Biochemical Pharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.